Khabarovsk's $16.5M tuberculosis ward opens to fight drug-resistant cases
Khabarovsk's $16.5M tuberculosis ward opens to fight drug-resistant cases
Khabarovsk's $16.5M tuberculosis ward opens to fight drug-resistant cases
A new tuberculosis ward has opened in Khabarovsk after years of construction. The facility, costing 1.5 billion rubles ($16.5 million), will treat the region's most severe cases. Equipped with advanced medical technology, it marks a major upgrade for healthcare in the Russian Far East.
The ward was built to address the region's ongoing tuberculosis problem. The Russian Far East remains an endemic zone for the disease, making specialised treatment essential. Officials have not released specific case numbers for 2023, but demand for care remains high.
The new facility spans multiple departments, including an admissions unit, a surgical ward, and three operating theatres. A dedicated unit for multidrug-resistant tuberculosis and a full laboratory are also part of the upgrade. Over 300 million rubles ($3.3 million) was spent on state-of-the-art equipment alone. Patient care has already begun, with surgeries taking place in the first weeks. One individual, who had failed to respond to medication for years, was successfully treated. The ward also features isolated high-dependency rooms and accessible areas for patients with disabilities. An intensive care unit now supports those recovering from operations or needing critical support. With space for 140 patients, the facility replaces older, less equipped wards. Early feedback has been positive, with one patient describing the conditions as comfortable and well-equipped.
The opening of the new ward provides Khabarovsk with a modern centre for tuberculosis treatment. Its specialised units and advanced technology aim to improve recovery rates for complex cases. The facility is now operational, accepting patients and conducting surgeries.